RemeGen
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
58号 烟台 开发区 中国, 烟台市, 山东省, 264000, ChinaWebsite
www.remegen.cnRevenue
$6.6 MillionIndustry
About RemeGen
荣昌生物制药（烟台）股份有限公司, co-founded in 2008 by Mr. Wang Weidong and Dr. Fang Jianmin, is headquartered in Yantai, Shandong, China, with research institutions in both China and the United States. The company specializes in innovative biopharmaceuticals, including the world's first dual-target therapy for systemic lupus erythematosus and China's first independently developed ADC drug. Their target clients include healthcare providers and patients suffering from major diseases, as they focus on enhancing the quality of life through advanced medical solutions. With a robust product pipeline and a commitment to research and development, 荣昌生物 aims to lead in the biopharmaceutical industry.Explore more
SIC Code 28,283NAICS Code 32,325Show more
RemeGen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
RemeGen Tech Stack
A closer look at the technologies used by RemeGen
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RemeGen
Sign Up For FreeTo access detailed company insights
荣昌生物制药（烟台）股份有限公司, co-founded in 2008 by Mr. Wang Weidong and Dr. Fang Jianmin, is headquartered in Yantai, Shandong, China, with research institutions in both China and the United States. The company specializes in innovative biopharmaceuticals, including the world's first dual-target therapy for systemic lupus erythematosus and China's first indep... Read More
